2026 Speakers
Patrick Day, Principal Consultant, Lachman Consultants
FDA Inspection Trends and Top Citations: A Focus on Facilities and Engineering
Dhaval Desai, Director of Regulatory Affairs & Supply Chain, Zydus Pharmaceuticals
From Approval to Availability: Strengthening the Regulatory-Supply Chain Connection
Romit Jani, Senior Director of Formulation Development, Solaris Pharma
From Formulation Development to Manufacturing Readiness: Working with CDMOs on Complex Product
Eric Langer, President and Managing Partner, BioPlan Associates, Inc.
The Biomanufacturing Capacity Crunch: Where CDMO Demand Is Still Outrunning Supply
Director, Regulatory Affairs, Amneal Pharmaceuticals
Before FDA Pushback: Using Regulatory Intelligence to De-Risk CMC Submissions
Michael Spangler, Principal Consultant, Spangler Consulting
Check Before You Choose: Making CDMO References Calls
